Cargando…
Using Mendelian randomization to understand and develop treatments for neurodegenerative disease
Common neurodegenerative diseases are thought to arise from a combination of environmental and genetic exposures. Mendelian randomization is a powerful way to leverage existing genetic data to investigate causal relationships between risk factors and disease. In recent years, Mendelian randomization...
Autores principales: | Storm, Catherine S, Kia, Demis A, Almramhi, Mona, Wood, Nicholas W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425289/ https://www.ncbi.nlm.nih.gov/pubmed/32954289 http://dx.doi.org/10.1093/braincomms/fcaa031 |
Ejemplares similares
-
Finding genetically-supported drug targets for Parkinson’s disease using Mendelian randomization of the druggable genome
por: Storm, Catherine S., et al.
Publicado: (2021) -
Exploring the Role of Plasma Lipids and Statin Interventions on Multiple Sclerosis Risk and Severity: A Mendelian Randomization Study
por: Almramhi, Mona M., et al.
Publicado: (2023) -
Mendelian Randomization Study Shows No Causal Relationship Between Circulating Urate Levels and Parkinson’s Disease
por: Kia, Demis A., et al.
Publicado: (2018) -
The Parkinson's Disease Mendelian Randomization Research Portal
por: Noyce, Alastair J., et al.
Publicado: (2019) -
Neurodegenerative disease and antioxidant biomarkers: A bidirectional Mendelian randomization study
por: Zhang, Qianqian, et al.
Publicado: (2023)